Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
CSP.L Share News (CSP)
CSP Share
Price
CSP Share
News
CSP Share
Chat
CSP Share
Trades
CSP
Live RNS
CSP Share
Charts
CSP Broker
Ratings
CSP Directors
Deals
CSP Financial
Diary
CSP
Fundamentals
CSP Short
Positions
CSP
Media
CSP Company
Research
CSP Company
Timeline
- There is currently no data for CSP
Wednesday broker round-up
Barclays: Berenberg reiterates buy with a target price of 220p.
Aston Martin: Citigroup reiterates buy with a target price of 2,800p.
Segro: JP Morgan reiterates neutral with a target price of 1,195p.
Sainsbury: Barclays reiterates overweight with a target price of 305p.
GlaxoSmithKline: Liberum reiterates buy with a target price of 1,700p.
On The Beach: Liberum reiterates hold with a target price of 380p.
888 Holdings: Peel Hunt reiterates buy with a target price of 500p.
Countryside Properties: Peel Hunt reiterates buy with a target price of 560p.
Redrow: Numis reiterates buy with a target price of 715p.
Accesso: Numis upgrades to buy with a target price of 800p.
International Airlines Group: Credit Suisse reiterates outperform with a target price of 256p.
Centrica: Credit Suisse reiterates outperform with a target price of 70p.
Latest CSP News
- Sigma Capital Buys Three Private Sector Sites To Deliver 214 New Homes
20 Apr 2018 - WINNERS & LOSERS SUMMARY: Reckitt Slides After Missing Forecasts
20 Apr 2018 - Countryside Properties Shareholder Oaktree Sells Entire 8% Stake (ALLISS)
20 Apr 2018 - Countryside Shareholder To Sell GBP134 Million Shares In Placing (ALLISS)
19 Apr 2018 - Countryside Has "Robust" Trading In First Half, Total Completions Up
18 Apr 2018 - Oaktree To Cut Stake In Countryside Properties Below Majority (ALLISS)
26 Jan 2017 - Countryside Properties remains confident for 2017 despite Brexit uncertainty
26 Jan 2017 - UK Shareholder Meetings Calendar - Next 7 Days
19 Jan 2017
Related News
GSK, Hansoh's targeted cancer drug hits main survival goal in China trial
* GSK partner Hansoh reports first late-stage data for experimental lung cancer drug
GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial
(Alliance News) - GSK PLC on Friday announced that risvutatug rezetecan has delivered "meaningful" survival data in a "pivotal" trial for advanced or ...
GSK hails 'milestone' drug trial results in China
(Sharecast News) - A targeted lung cancer treatment developed by GSK has shown promising results in the latest trials in China, the pharma blue chip c...
CSP.L News
Sigma Capital Buys Three Private Sector Sites To Deliver 214 New Homes
LONDON (Alliance News) - Sigma Capital Group PLC on Friday said it intends to buy three private rented sector sites in the North West and West Midland...
WINNERS & LOSERS SUMMARY: Reckitt Slides After Missing Forecasts
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - LOSERS-...
Countryside Properties Shareholder Oaktree Sells Entire 8% Stake (ALLISS)
LONDON (Alliance News) - Oaktree Capital Management LP unit OCM Luxembourg Coppice Topco Sarl has completed the sale of its remaining interest of 36.2...
Countryside Shareholder To Sell GBP134 Million Shares In Placing (ALLISS)
LONDON (Alliance News) - Jefferies International Ltd said on Thursday that OCM Luxembourg Coppice Topco Sarl plans to sell its remaining 36.2 million ...
Countryside Has "Robust" Trading In First Half, Total Completions Up
LONDON (Alliance News) - Countryside Properties PLC said Wednesday its first half completions and revenue were in line with expectations.Total complet...
Countryside Properties remains confident for 2017 despite Brexit uncertainty
(ShareCast News) - Countryside Properties quarterly completions rose as its average selling price increased with the housebuilder confident for its fu...
Follow the stocks
